 Estrogens
"Estrogens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds.
| Descriptor ID |
D004967
|
| MeSH Number(s) |
D27.505.696.399.472.277
|
| Concept/Terms |
Estrogens- Estrogens
- Estrogenic Compounds
- Compounds, Estrogenic
- Estrogen
- Estrogenic Agents
- Agents, Estrogenic
Estrogen Effect- Estrogen Effect
- Effect, Estrogen
- Estrogenic Effect
- Effect, Estrogenic
- Estrogenic Effects
- Effects, Estrogenic
- Estrogen Effects
- Effects, Estrogen
|
Below are MeSH descriptors whose meaning is more general than "Estrogens".
Below are MeSH descriptors whose meaning is more specific than "Estrogens".
This graph shows the total number of publications written about "Estrogens" by people in this website by year, and whether "Estrogens" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 3 | 3 | | 1982 | 1 | 1 | 2 | | 1983 | 1 | 1 | 2 | | 1984 | 1 | 0 | 1 | | 1985 | 0 | 1 | 1 | | 1986 | 1 | 0 | 1 | | 1987 | 2 | 1 | 3 | | 1988 | 0 | 3 | 3 | | 1989 | 3 | 2 | 5 | | 1990 | 1 | 1 | 2 | | 1992 | 1 | 0 | 1 | | 1994 | 1 | 1 | 2 | | 1995 | 3 | 1 | 4 | | 1996 | 1 | 1 | 2 | | 1997 | 2 | 0 | 2 | | 1998 | 4 | 0 | 4 | | 1999 | 1 | 0 | 1 | | 2000 | 3 | 3 | 6 | | 2001 | 1 | 1 | 2 | | 2002 | 5 | 4 | 9 | | 2003 | 3 | 2 | 5 | | 2004 | 1 | 2 | 3 | | 2005 | 1 | 1 | 2 | | 2006 | 1 | 5 | 6 | | 2007 | 2 | 3 | 5 | | 2008 | 4 | 2 | 6 | | 2009 | 4 | 3 | 7 | | 2010 | 3 | 3 | 6 | | 2011 | 0 | 1 | 1 | | 2012 | 1 | 4 | 5 | | 2013 | 1 | 4 | 5 | | 2014 | 1 | 0 | 1 | | 2015 | 0 | 1 | 1 | | 2016 | 2 | 0 | 2 | | 2017 | 1 | 0 | 1 | | 2018 | 2 | 2 | 4 | | 2019 | 1 | 2 | 3 | | 2020 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Estrogens" by people in Profiles.
-
Ali M, Shahin SM, Sabri NA, Al-Hendy A, Yang Q. Activation of ß-Catenin Signaling and its Crosstalk With Estrogen and Histone Deacetylases in Human Uterine Fibroids. J Clin Endocrinol Metab. 2020 04 01; 105(4).
-
Feng H, Gusev A, Pasaniuc B, Wu L, Long J, Abu-Full Z, Aittomäki K, Andrulis IL, Anton-Culver H, Antoniou AC, Arason A, Arndt V, Aronson KJ, Arun BK, Asseryanis E, Auer PL, Azzollini J, Balmaña J, Barkardottir RB, Barnes DR, Barrowdale D, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bialkowska K, Blanco A, Blomqvist C, Boeckx B, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Borg A, Brauch H, Brenner H, Briceno I, Broeks A, Brüning T, Burwinkel B, Cai Q, Caldés T, Caligo MA, Campbell I, Canisius S, Campa D, Carter BD, Carter J, Castelao JE, Chang-Claude J, Chanock SJ, Christiansen H, Chung WK, Claes KBM, Clarke CL. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. Genet Epidemiol. 2020 07; 44(5):442-468.
-
Schlaff WD, Ackerman RT, Al-Hendy A, Archer DF, Barnhart KT, Bradley LD, Carr BR, Feinberg EC, Hurtado SM, Kim J, Liu R, Mabey RG, Owens CD, Poindexter A, Puscheck EE, Rodriguez-Ginorio H, Simon JA, Soliman AM, Stewart EA, Watts NB, Muneyyirci-Delale O. Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids. N Engl J Med. 2020 01 23; 382(4):328-340.
-
Adeleye AJ, Cedars MI, Smith J, Mok-Lin E. Ovarian stimulation for fertility preservation or family building in a cohort of transgender men. J Assist Reprod Genet. 2019 Oct; 36(10):2155-2161.
-
Mitchell CM, Guthrie KA, Larson J, Diem S, LaCroix AZ, Caan B, Shifren JL, Woods NF, Heiman JR, Lindau ST, Reed SD. Sexual frequency and pain in a randomized clinical trial of vaginal estradiol tablets, moisturizer, and placebo in postmenopausal women. Menopause. 2019 08; 26(8):816-822.
-
Zhang Z, Tremblay J, Raelson J, Sofer T, Du L, Fang Q, Argos M, Marois-Blanchet FC, Wang Y, Yan L, Chalmers J, Woodward M, Harrap S, Hamet P, Luo H, Wu J. EPHA4 regulates vascular smooth muscle cell contractility and is a sex-specific hypertension risk gene in individuals with type 2 diabetes. J Hypertens. 2019 04; 37(4):775-789.
-
Carr BR, Stewart EA, Archer DF, Al-Hendy A, Bradley L, Watts NB, Diamond MP, Gao J, Owens CD, Chwalisz K, Duan WR, Soliman AM, Dufek MB, Simon JA. Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial. Obstet Gynecol. 2018 11; 132(5):1252-1264.
-
Katzenellenbogen JA, Mayne CG, Katzenellenbogen BS, Greene GL, Chandarlapaty S. Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance. Nat Rev Cancer. 2018 06; 18(6):377-388.
-
Thompson EE, Nicodemus-Johnson J, Kim KW, Gern JE, Jackson DJ, Lemanske RF, Ober C. Global DNA methylation changes spanning puberty are near predicted estrogen-responsive genes and enriched for genes involved in endocrine and immune processes. Clin Epigenetics. 2018; 10:62.
-
Klein KO, Rosenfield RL, Santen RJ, Gawlik AM, Backeljauw PF, Gravholt CH, Sas TCJ, Mauras N. Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations. J Clin Endocrinol Metab. 2018 05 01; 103(5):1790-1803.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|